Electroceuticals: Technologies and Global Markets

Report Scope:

This report provides a comprehensive summary of electroceutical technologies and global markets, along with detailed profiles of key market players, a revenue product portfolio and recent activities. This report analyzes trends and dynamics, including drivers, limitations, challenges and opportunities. This report discusses strategies adopted by emerging market players, with recommendations for new market entrants. This research study discusses historical, current and potential market size. This report will help market players and new entrants make informed decisions about the production and export of goods and services. Organizations, distributors and exporters should find the information about market development and trends useful. This study segments the market on the basis of applications and end use. Geographic market analysis is provided for all major segments.

Report Includes:

- 29 data tables and 24 additional tables
- An overview of global markets and technologies for electroceuticals
- Analyses of global market trends, with data from 2018, estimates for 2019, and projections of compound annual growth rates (CAGRs) through 2024
- Discussion on why electroceuticals are considered as an alternative to drug-based remedies
- Identification of endogenous and exogenous factors that are impacting the global market growth
- Coverage of several diseases such as epilepsy, cardiovascular diseases, rheumatoid arthritis and diabetes and their treatment using electroceuticals
- Information on RecoveryRx medical device, which is used for the treatment of postoperative pain of opioid/NSAID therapy
- Comprehensive profiles of leading companies in the industry, including Abbott Laboratories Inc., Biotronik Inc., Cochlear Corp., GlaxoSmithKline Plc and Sonova AG

Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Geographic Breakdown
Analysts Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
Market Definition
North America
Cardioverter Defibrillators and Cardiac Pacemaker Segment
Public Access Defibrillators (PAD)
Asia Pacific
Battery Technology
Factors Driving Market Growth
Product Launch
Growing Geriatric Population
Factors Restraining Market Growth
Alternative Drugs: Treatment of Arrhythmia
Stringent Government Regulations
Hackable Pacemakers
Low Awareness
Growing Healthcare Expenditures
Chapter 4 Market Breakdown by Technology Type
Cardioverter Defibrillators and Cardiac Pacemakers
Deep Brain Stimulators (DBS)
Spinal Cord Stimulators (SCS)
Vagus Nerve Stimulators
Hearing Aids and Cochlear Implants
Others (Sacral Nerve Stimulators, Transcutaneous Electrical Nerve Stimulators)
Chapter 5 Market Breakdown by End User
Hospitals and Clinics
Homecare and Others
Chapter 6 Market Breakdown by Region
North America